Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, and Ashoka, the world’s largest network of social entrepreneurs, have held a co-creation workshop for the ‘Making More Health’ (MMH) Accelerator in Nairobi, Kenya.
The MMH Accelerator program supports social entrepreneurs in the healthcare space to strengthen and scale their work. The program brings together some of the best experiences in social innovation and global health to improve access to healthcare systemsacross Sub-Saharan Africa.
Along with capacity building as well as technical and financial support to develop, pilot and test their co-creation ideas with Boehringer Ingelheim and Ashoka, the social entrepreneurs participating in the program will receive trainings on business model innovation, market strategy and scaling models. Through the accelerator process, social entrepreneurs participating in the Accelerator will have access to a network of professional support, including Boehringer Ingelheim and Ashoka experts.
The MMH Accelerator combines Ashoka’s expertise in social entrepreneurship with Boehringer Ingelheim’s business acumen and knowledge of the healthcare industry. The participating projects address several themes such as providing medical care in remote areas in a more effective and sustainable manner, digital platforms that support integrated care for patients with chronic diseases, and increasing transparency within the pharmaceutical supply chain.
“Over the years, our social initiatives in Kenya have been connecting people with timely and effective healthcare solutions,” said Mr Simon Manyara, Access to Healthcare Manager at Boehringer Ingelheim. “These co-creation thinking workshops, as part the accelerator, are helping address the most critical topics. We want to foster local social innovation and increase access to healthcare among underserved communities and strengthen the potential of these projects through the immense knowledge pool within our talent and global operations network.”
Launched in 2010 to mark the 125th years of Boehringer Ingelheim, MMH is a global social entrepreneurial initiative that seeks to support the health of people, their families and the social environment by identifying and supporting promising solutions to improve health systems globally.
All-round approach will prevent tax offences and financial crimes
Kenya has become increasingly exposed to illicit products and counterfeit goods, hence the need to take an all-round approach towards...
Kenya’s GDP to hit 5.7% despite debt burden
Despite a debt increase, Kenya’s GDP is expected to reach 5.7% up from 4.9% last year, according to ICAEW’s (the...
DPP seeks to withdraw forgery case in Sh500m Karen land suit
The Director of Public Prosecutions (DPP) has requested for withdrawal of the case against Guy Spencer Elms, the lawyer accused...
Chebukati ‘out to fix Chiloba’
When Judge Stephen Radido delivered his ruling on Thursday setting aside IEBC chairman Wafula Chebukati’s decision to send the CEO,...
Pharmaceutical firm backs social investments in healthcare
Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, and Ashoka, the world’s largest network of social entrepreneurs, have held...
MKU ranked among 10 best universities in Kenya
Four local private universities in top 10 ranking of universities in the country.
4 MultiChoice traders win trip to watch World Cup in Russia
They will have an experience of a lifetime touring Petersburg, the Vodka Museum and enjoy a private boat tour along...
Inside the boda boda millionaire industry
In small doses of Sh50 and Sh100, Kenyans spend Ksh600 million daily on motorcycle services
Daystar University sacks vice-chancellor
Striking students had decried mismanagement of funds and quality of education
Battle for Machakos governor heads to the Supreme Court
The court faulted the IEBC returning officer for using an excel spreadsheet to record results instead of Form 37A